Cancer patients may soon have a new tool to help determine if certain treatments will be effective in their care.
British scientists have developed a new genetic test that experts say is one of the most promising applications of personalized medicine, where a patient’s care is designed around his or her particular biological makeup.
The new test uses the latest DNA sequencing techniques to detect mutations in 46 genes known to drive cancer growth in patients with solid tumors — and, in turn, may potentially determine which treatment a patient should receive.
It has been launched by the U.K. National Health Service in a partnership with scientists at the University of Oxford and Oxford University Hospitals NHS Trust. It will be run by the National Institute for Health Research Oxford Biomedical Research Centre (BRC) and initially include all cancer patients in the Thames Valley area. But the scientists hope to expand the program nationally by year’s end.
The researchers who developed the test said it represents a leap forward in introducing next-generation DNA sequencing technology that heralds the dawn of a new age in medicine.
“We are the first to introduce a multi-gene diagnostic test for tumor profiling on the NHS using the latest DNA sequencing technology,” said Jenny Taylor, M.D., of the Wellcome Trust Centre for Human Genetics at Oxford University and program director for Genomic Medicine at the BRC.
“It’s a significant step change in the way we do things. This new 46-gene test moves us away from conventional methods for sequencing of single genes, and marks a huge step towards more comprehensive genome sequencing in both infrastructure and in handling the data produced.”
Researchers said the new test, which costs several hundred dollars to administer, could save significantly more in drug costs by getting patients on to the right treatments, reducing harm from side effects as well as the time lost before identifying at an effective treatment.
The Latest Bing News on:
Cancer gene test
- People at higher risk of getting cancer left waiting over a year for vital genetic testson April 14, 2021 at 12:09 am
People at a higher risk of getting cancer are having to wait over a year for genetic tests due to services being 'overstretched', a report has found. Inherited faulty genes play a major role in 5% to ...
- People waiting over a year for cancer risk tests due to 'overstretched' services, report suggestson April 13, 2021 at 11:30 pm
PEOPLE AT A higher risk of cancer due to their family history are having to wait over a year for tests due to “overstretched” services, a new report has suggested. Inherited faulty genes play a major ...
- People with family history of cancer waiting two years for genetic testing, study findson April 13, 2021 at 6:30 pm
People with a family history of cancer are still having to wait up to two years or more for genetic testing that could otherwise alert them before they go on to develop the disease, a new study by ...
- Hereditary Cancer Testing Market Share, Growth, PESTL, Posters Five Analysis 2021-2025on April 13, 2021 at 11:21 am
The Top key vendors in Hereditary Cancer Testing Market include are:-Myriad Genetics, Myogenes, Laboratory Corporation of America, Biocartis, Quest Diagnostics, Pathway Genomics, Invitae Corporation, ...
- Cancer DNA Blood Tests Validated – Fast, Cheap and Less Invasive Method to Diagnose and Monitor Canceron April 13, 2021 at 7:29 am
The researchers revealed that all assays could reliably detect so-called circulating tumor DNA (ctDNA) when it made up 0.5% of the total DNA in blood, a level of sensitivity that allows detection, ...
- Global Genetic Testing Market Report 2021-2025: Newborn, NIPT, Predictive, Oncology, DTC, Others - COVID-19 Crowds Out Other Serviceson April 13, 2021 at 1:38 am
3.3.2 Bioinformatics Plays a Role. 3.4 Diagnostic Technology Development 3.4.1 Next Generation Sequencing Fuels a Revolution.
- After Losing Our Dad to Pancreatic Cancer, We Got Genetic Testingon April 10, 2021 at 8:00 am
In honor of Siblings Day, the Soukup sisters share their journey and why they decided to get genetic testing. After 16 months of surgeries, chemo treatments, infections, hospital stays and ...
- YOUR HEALTH: An at-home cancer test that's calming nerveson April 9, 2021 at 5:12 pm
Adriana was determined to know her genetic cancer risks, so she signed up to take part in the Magenta trial. One of the goals is to make genetic testing accessible to everyone by providing at-home ...
- Global Breast Cancer Predictive Genetic Testing Market Size, Share, Value, and Competitive Landscape 2021-2027on April 8, 2021 at 5:58 am
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a ...
- Racial disparities still persist in genetic testing for BRCA-related breast canceron April 7, 2021 at 2:04 pm
West Philly native shares her cancer journey as part of Penn Medicine's effort to boost testing rates among Black patients ...
The Latest Google Headlines on:
Cancer gene test
[/vc_column_text]
The Latest Bing News on:
DNA sequencing
- Cancer DNA Blood Tests Validated – Fast, Cheap and Less Invasive Method to Diagnose and Monitor Canceron April 13, 2021 at 7:29 am
An international team today reports the findings of an independent assessment of five commercially-available assays for tumor DNA sequencing – a fast, cheap and less invasive method to diagnose and ...
- Moss enables high sensitivity single-nucleotide variant calling from multiple bulk DNA tumor sampleson April 13, 2021 at 5:35 am
The study of tumour heterogeneity can be improved by sequencing multiple samples, but currently available variant callers have not been tailored to integrate them. Here the authors present Moss, a ...
- DNA Sequencing Is Cracking Down on Shark Poachingon April 13, 2021 at 4:02 am
We empower the curious to understand the science shaping our world. Uncover the natural forces and innovations impacting our lives, our planet and our universe.
- DSU Establishes DNA Core Centeron April 12, 2021 at 12:53 pm
He said the funding enable the university to build the center through the acquisition of an Illumina Sequencer, PacBio Sequencer and a sequencing library preparation system. Lee said there are three ...
- Cancer DNA blood tests validated by international research teamon April 12, 2021 at 8:00 am
An international team today reports the findings of an independent assessment of five commercially-available assays for tumor DNA sequencing—a fast, cheap and less invasive method to diagnose and ...
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncologyon April 11, 2021 at 5:00 pm
Reliable detection of mutations below 0.5% variant allele frequency remains a key challenge for circulating tumor DNA sequencing assays.
- Scientists can now silence genes without altering underlying DNA sequenceon April 9, 2021 at 10:34 am
Scientists have developed a tool that can precisely control gene expression without altering the underlying DNA sequence.
- New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchangedon April 9, 2021 at 8:09 am
Over the past decade, the CRISPR-Cas9 gene editing system has revolutionized genetic engineering, allowing scientists to make targeted changes to organisms' DNA. While the system could potentially be ...
- DNA Sequencing Market | Dynamics, Market Size, Analysis, Development, Revenue, Future Growth, Business Prospects and Forecast to 2027on April 6, 2021 at 11:56 pm
The Global DNA Sequencing Market size is expected to gain momentum backed by the increasing incidence of suicides and ...
- Glass nanopore pulls DNA like spaghetti through a needleon April 6, 2021 at 7:11 am
(Nanowerk News) DNA sequencing has become so common, few realize how hard it is to even extract a single molecule of DNA from a biological sample. Research led by UC Riverside is making it easier to ...